These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25833728)

  • 21. Removing Disincentives to Kidney Donation: A Quantitative Analysis.
    McCormick F; Held PJ; Chertow GM; Peters TG; Roberts JP
    J Am Soc Nephrol; 2019 Aug; 30(8):1349-1357. PubMed ID: 31345987
    [No Abstract]   [Full Text] [Related]  

  • 22. The Ethics of Promoting Living Kidney Donation Using Nonargumentative Influence: Applications, Concerns, and Future Directions.
    Allen MB; Reese PP
    Am J Transplant; 2016 Dec; 16(12):3378-3384. PubMed ID: 27438695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From potential donor to actual donation: does socioeconomic position affect living kidney donation? A systematic review of the evidence.
    Bailey P; Tomson C; Risdale S; Ben-Shlomo Y
    Transplantation; 2014 Nov; 98(9):918-26. PubMed ID: 25250649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensated kidney donation: an ethical review of the Iranian model.
    Bagheri A
    Kennedy Inst Ethics J; 2006 Sep; 16(3):269-82. PubMed ID: 17091561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial compensation for organ donors.
    Harbell JW; Mathur AK
    Curr Opin Organ Transplant; 2019 Apr; 24(2):182-187. PubMed ID: 30762665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introducing incentives in the market for live and cadaveric organ donations.
    Becker GS; Elias JJ
    J Econ Perspect; 2007; 21(3):3-24. PubMed ID: 19728419
    [No Abstract]   [Full Text] [Related]  

  • 27. Incentive models to increase living kidney donation: encouraging without coercing.
    Israni AK; Halpern SD; Zink S; Sidhwani SA; Caplan A
    Am J Transplant; 2005 Jan; 5(1):15-20. PubMed ID: 15636607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health Insurance Trends in United States Living Kidney Donors (2004 to 2015).
    Rodrigue JR; Fleishman A
    Am J Transplant; 2016 Dec; 16(12):3504-3511. PubMed ID: 27088263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public survey of financial incentives for kidney donation.
    Kranenburg L; Schram A; Zuidema W; Weimar W; Hilhorst M; Hessing E; Passchier J; Busschbach J
    Nephrol Dial Transplant; 2008 Mar; 23(3):1039-42. PubMed ID: 18029378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse?
    Hippen B; Matas A
    Curr Opin Organ Transplant; 2009 Apr; 14(2):140-6. PubMed ID: 19307965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Financial Neutrality for Living Organ Donors: Reasoning, Rationale, Definitions, and Implementation Strategies.
    Hays R; Rodrigue JR; Cohen D; Danovitch G; Matas A; Schold J; LaPointe Rudow D
    Am J Transplant; 2016 Jul; 16(7):1973-81. PubMed ID: 27037542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In defense of a regulated system of compensation for living donation.
    Matas AJ; Hippen B; Satel S
    Curr Opin Organ Transplant; 2008 Aug; 13(4):379-85. PubMed ID: 18685333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study.
    Rodrigue JR; Schold JD; Morrissey P; Whiting J; Vella J; Kayler LK; Katz D; Jones J; Kaplan B; Fleishman A; Pavlakis M; Mandelbrot DA;
    Am J Transplant; 2015 Sep; 15(9):2387-93. PubMed ID: 25943721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the possibility of adopting financially driven live donor kidney transplantation.
    Yacoubian AA; Dargham RA; Khauli RB
    Int Braz J Urol; 2018; 44(6):1071-1080. PubMed ID: 30044592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'It's a regional thing': financial impact of renal transplantation on live donors.
    McGrath P; Holewa H
    Rural Remote Health; 2012; 12():2144. PubMed ID: 23127520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy options for increasing the supply of transplantable kidneys in Singapore.
    Chong JL
    Singapore Med J; 2016 Oct; 57(10):530-532. PubMed ID: 27779281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the likely harms to kidney vendors in regulated organ markets.
    Koplin J
    Am J Bioeth; 2014; 14(10):7-18. PubMed ID: 25229573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From blood donation to kidney sales: the gift relationship and transplant commercialism.
    Koplin JJ
    Monash Bioeth Rev; 2015; 33(2-3):102-22. PubMed ID: 26458365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study.
    Rodrigue JR; Schold JD; Morrissey P; Whiting J; Vella J; Kayler LK; Katz D; Jones J; Kaplan B; Fleishman A; Pavlakis M; Mandelbrot DA;
    Am J Transplant; 2016 Mar; 16(3):869-76. PubMed ID: 26845630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussion on transplant ethics.
    Patil R
    Issues Med Ethics; 2002; 10(3):62. PubMed ID: 16335488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.